SFI
CANF

Susquehanna Fundamental Investments’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Susquehanna Fundamental Investments’s Portfolio CANF Stock Details CANF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-87
Closed -$31K – 1535
2020
Q4 		$31K Hold
87
– – ﹤0.01% 1464
2020
Q3 		$31K Buy
+87
New +$36.3K ﹤0.01% 1337

Other funds holding CANF

CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna Fundamental Investments's CANF Position: Q1 2021 in Review

Susquehanna Fundamental Investments sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q1 2021, closing a stake of 87 shares — an estimated $31K sold.

Susquehanna Fundamental Investments first reported a position in CANF in Q3 2020 and held it in 2 quarters. The position peaked at $31K in Q4 2020. 13 funds tracked by Wall St. Rank hold CANF as of Q1 2021.

  • Susquehanna Fundamental Investments reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 87 Can-Fite BioPharma American Depositary Shares shares in Q1 2021, an estimated $31K.
  • Susquehanna Fundamental Investments first reported a position in Can-Fite BioPharma American Depositary Shares in Q3 2020 and held it in 2 quarters.
  • Susquehanna Fundamental Investments's Can-Fite BioPharma American Depositary Shares position peaked at $31K in Q4 2020.
  • 13 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q1 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2021, filed 17 May 2021.